Marimed (MRMD) Total Liabilities (2011 - 2026)

Marimed (MRMD) has 16 years of Total Liabilities data on file, last reported at $147.7 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 10.2% year-over-year to $147.7 million in Q1 2026; TTM through Mar 2026 was $147.7 million, a 10.2% increase from a year earlier, with the FY2025 full-year figure at $137.8 million, up 6.48% from the prior year.
• Total Liabilities for Q1 2026 stood at $147.7 million, up from $137.8 million in the prior quarter.
• Over the last five years, Total Liabilities for MRMD reached as high as $147.7 million in Q1 2026 and fell as low as $50.7 million in Q2 2022.
• Historically, Total Liabilities has averaged $103.7 million across 5 years, with a median of $113.5 million in 2024.
• Across the five-year window, Total Liabilities soared 87.54% in 2023 and rose 6.48% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $57.2 million in 2022, then jumped by 87.54% to $107.2 million in 2023, then grew by 20.74% to $129.4 million in 2024, then rose by 6.48% to $137.8 million in 2025, then climbed by 7.19% to $147.7 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $147.7 million in Q1 2026, $137.8 million in Q4 2025, and $136.6 million in Q3 2025.